HUMAN CHORIONIC GONADOTROPIN BETA (BHCG) - TUMOR MARKER/CONGENITAL DISORDERS - ANVISA Registration 10009010398

Access comprehensive regulatory information for HUMAN CHORIONIC GONADOTROPIN BETA (BHCG) - TUMOR MARKER/CONGENITAL DISORDERS in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 10009010398 and manufactured by LABTEST DIAGNOSTICA S/A. The registration is held by LABTEST DIAGNOSTICA S/A with validity until Mar 10, 2035.

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including ROCHE DIAGNOSTICS GMBH, B-R-A-H-M-S GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.